References
- Hoffman RS. Off-label uses for selective serotonin reuptake inhibitors. Am Fam Physician. 2005;71(1):43.
- Ozyalcin SN, Talu GK, Kiziltan E, et al. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache. 2005;45(2):144–152.
- Rowbotham MC, Goli V, Kunz NR, et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy a double-blind, placebo-controlled study. Pain. 2004;110(3):697–706.
- Chober CE, Ansani NT. Venlafaxine hydrochloride for the treatment of hot flashes. Ann Pharmacother. 2003;37:1703–1707.
- Lockhart P, Guthrie B. Trends in primary care antidepressant prescribing 1995–2007: a longitudinal population database analysis. Br J Gen Pract. 2011;61(590):e565–72.
- Venlafaxine Hydrochloride: Drug Usage Statistics, United States, 2006–2016. Medical Expenditure Panel Survey (MEPS) 2006–2016. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ). ClinCalc DrugStats Database version 19.1.
- Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Q J Med. 2003;96(5):369–374.
- Schlienger RG, Klink MH, Eggenberger C, et al. Seizures associated with therapeutic doses of venlafaxine and trimipramine. Ann Pharmacother. 2000;34(12):1402–1405.
- Touchet BK, Brahn MC, Fox MD. A case of seizure activity associated with therapeutic dose of venlafaxine. Prim Care Companion CNS Disord. 2013;15(1):PCC.12l01479.
- Thundiyil JG, Kearney TE, Olson KR. Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System. J Med Toxicol. 2007;3(1):15–19.
- Sarandol A, Taneli B. Seizure activity after venlafaxine overdose. J Pharm Technol. 2003;19(6):358–360.
- Chema N, Leikin JB. Delayed seizure due to venlafaxine ER and lamotrigine overdose (Abstract). Clin Toxicol. 2014;52(7):812–813.
- Kumar VVP, Oscarsson S, Friberg LE, et al. The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose. Clin Pharmacol Ther. 2009;86(4):403–410.
- Hoffman RS. Understanding the limitations of retrospective analyses of poison center data. Clin Toxicol. 2007;45(8):943–945.
- Bourin M. Psychopharmacological profile of venlafaxine. Encephale. 1999;25(2):21–22.
- Santos JG, Do Monte FHM, Russi M, et al. Proconvulsant effects of high doses of venlafaxine in pentyltetrazole-convulsive rats. Braz J Med Biol Res. 2002;35:469–472.